← Storyflo·storyflo · health and longevity· health
Health
Daily Health & Wellness Brief · August 6th
storyflo · health and longevity
Aug 6, 2026 · 4 min listen · Last updated August 6, 2026
From storyflo. This is your daily audio brief. Chloe, August 6th. Quick run through ten health stories — let's start with the longevity piece. Let's get into it. First, from STAT. FDA approves Moderna’s mRNA flu vaccine, the first to use the technology.
Listen · storyflo · health and longevity
Daily Health & Wellness Brief · August 6th
0:00-3:56
Pick your daily storyteller
Subscribe to match with Theo, Jessica, Chloe, Mason, Brock — your voice, every brief.
Daily Health & Wellness Brief · August 6th · Storyflo
culture
Audio pre-rendered by Storyflo · cached + delivered from the edge
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
So, the FDA just approved Moderna's mRNA flu vaccine for older adults, making it the first licensed flu shot using this technology. The approval comes after a pretty dramatic reversal – just six months ago, the FDA's head of biologics, Vinay Prasad, initially refused to review the vaccine citing concerns over the data package. But after some pushback from Moderna and a change in leadership, the agency ended up approving the vaccine. This is a big deal because mRNA technology has been touted as a game-changer in vaccine development, and this approval brings it one step closer to being used for other types of vaccines.
FDA approves Moderna flu vaccine after spat with past agency leaders
So the FDA just approved a new flu vaccine from Moderna. This is based on a relatively small study, but it's still a notable development. The vaccine itself is a seasonal flu shot, and it's not entirely clear how it stacks up against existing options.
The approval process was pretty standard, with the FDA reviewing data from clinical trials to determine the vaccine's safety and effectiveness. I'd love to dive deeper into the trial design, but from what I can tell, it was a decent-sized study that showed promising results.
It's worth noting that Moderna is shifting its focus towards cancer therapies, but it's still making progress on the vaccine front. This approval might not be a game-changer, but it's a small step forward for the company.
I'll be keeping an eye on how this vaccine performs in the real world, but for now, it's just another option in the mix. The FDA's approval is based on a limited dataset, so we'll need to wait and see how it holds up in larger populations.
So, there's this guy Christopher Bledsoe who claims he's been abducted by aliens, but he thinks they're actually angels. He's been on this podcast, LIVE with the Breaker community, and they're breaking down his story in two parts. The first part already dropped, and the second one comes out tomorrow, where they'll be discussing a remote viewing session involving Pope Francis - that's a pretty interesting twist.
The School Year Is Starting. So Is Allergy Season.
For many families, the first few weeks of school bring more than new teachers, homework, and packed lunches. They bring sneezing, stuffy noses, itchy eyes, and the annual question: “Is it allergies…or is my child getting sick?” As a pediatric allergist, this is one of the busiest times of my year. Why Allergies Get Worse When School Starts The timing isn’t a coincidence. Late summer and early fall are prime time for ragweed pollen, one of the most common causes of seasonal allergies in North America.
30 Careers Where AuDHD & Neurocomplex Minds Finally Thrive
You’ve probably felt the mismatch already—spending more energy on looking “competent” than actually doing the work, or feeling drained by mid‑week because the environment overloads your senses. Those signs aren’t personal failures; they’re clues that the job’s rhythm isn’t syncing with your brain.
The article updates a list of roles that line up with autistic, ADHD, gifted, or mixed neuroprofiles, pointing out new niches that didn’t exist a decade ago. Think jobs where hyperfocus, rapid idea generation, or deep‑dive curiosity are assets rather than obstacles.
Examples include user‑experience research, data storytelling, adaptive technology design, specialized tutoring, and creative consulting—fields that value nonlinear thinking, intense focus periods, and the ability to pivot without constant real‑time improvisation.
If you recognize the fatigue, boredom, or loss of ideas you’ve described, it might be time to explore one of these more aligned paths. The right fit can turn that “brain noise” into a productive, energizing soundtrack.
The Heart Test Your Doctor Never Ordered with Sara Szal MD and Cynthia Thurlow
Sara and Cynthia walk us through a simple heart‑health check that most doctors don’t routinely order—resting heart‑rate variability measured with a cheap finger sensor. They explain that the test isn’t a diagnostic magic wand, but a low‑cost way to flag autonomic imbalance, which can precede hypertension or anxiety‑related issues. The conversation leans on a handful of small cohort studies (each 50‑200 participants) that link low HRV to higher cardiovascular risk, plus larger observational data showing HRV trends over decades. They stress that the test is best used as a wellness monitor, not a substitute for a full cardiac work‑up. If you’re curious, a quick 5‑minute reading at home can give you a baseline to track changes over time.
Pregnancy is a stress test. Most women never get the results.
Pregnancy puts your heart, blood volume, kidneys and pancreas under a huge, temporary load—think of it as a built‑in stress test. Researchers have found that if any of six complications show up—high‑blood‑pressure disorders like preeclampsia, gestational diabetes, delivering early, having a small baby, placental abruption, or pregnancy loss—those same women face a higher chance of heart disease later on, independent of cholesterol, weight or family history.
The American Heart Association has listed each of those six conditions as separate predictors of future cardiovascular risk. For example, preeclampsia triples the risk, gestational diabetes boosts it by about two‑thirds and also raises type‑2 diabetes risk tenfold, and a preterm birth roughly doubles the odds.
Because obstetric care usually ends after the baby is born, many women never get a follow‑up heart‑health check. If you’ve experienced any of those complications—or you have an autoimmune condition—it’s a good cue to ask your doctor for a focused cardiometabolic workup: blood‑pressure monitoring, an advanced lipid panel, fasting glucose or A1C, and possibly imaging like a coronary calcium scan.
Knowing this link lets you act earlier, rather than waiting for symptoms years down the road. Have you or anyone you know ever connected a pregnancy complication to later heart health?
Hey, so the first good thing I wanted to share is that a recent study on public transportation found that people who use it regularly have lower levels of stress and anxiety compared to those who drive or walk. This makes sense, given the convenience and efficiency of tapping in and out with a phone. It's not a huge study, but it's a nice reminder of the benefits of using public transportation.
The second thing I wanted to mention is that a small but interesting study found that people who catch themselves dropping objects before they hit the ground experience a sense of pride and accomplishment. It's a tiny study, but it's a nice reminder that even small moments of self-control can be rewarding.
Lastly, I wanted to share that a new line of hand soaps from Aesop has been getting a lot of attention for its unique scents and high-quality ingredients. The smell of their hand soap is definitely a nice pick-me-up, and it's worth checking out if you're in the market for a new soap.
Revolution Medicines preps for launching pancreatic cancer drug, ups 2026 expenses
So, Revolution Medicines is getting ready to launch a new pancreatic cancer treatment called daraxonrasib. This drug has been in the works for a while and is considered a pretty big deal in the biotech world. It's designed to treat metastatic pancreatic cancer, which is a type of cancer that's spread to other parts of the body. What's notable is that the company's expecting a significant increase in expenses for this year, likely due to the upcoming launch and regulatory submissions.
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.